The largest database of trusted experimental protocols

6 protocols using calf intestine phosphatase

1

Generating SaCas9/anti-HERV-K Constructs

Check if the same lab product or an alternative is used in the 5 most similar protocols
To create the SaCas9/anti-HERV-KenvgRNA constructs, we used the existing pX601-AAV-CMV::NLS-SaCas9-NLS-3xHA-bGHpA;U6::Bsa1-sgRNA plasmid (Addgene, #61591), consisting of a Staphylococcus aureus-derived SaCas9/gRNA system, adapted for use in mammalian cells [33 (link)]. Protospacer regions corresponding to selected target sites were ordered, as a pair of 5′-G(N22)-3′ complementary oligonucleotides, containing Bsa1 overhangs at their respective 5′ ends. After annealing and phosphorylation by T4 polynucleotide kinase (New England Biolabs), double stranded protospacers were ligated into the Bsa1-digested pX601 backbone plasmid, which was dephosphorylated with calf intestine phosphatase (New England Biolabs, #M0290S). Bacterial clones were screened by PCR for the presence of gRNA protospacer inserts, using the top forward oligonucleotide of each annealed gRNA, in combination with reverse primer specific for the gRNA scaffold segment of U6-gRNA cassette. Successful clones were further verified by sequencing, using the same reverse primer.
+ Open protocol
+ Expand
2

BIK1 Phosphorylation Analysis in Flg22-Treated Protoplasts

Check if the same lab product or an alternative is used in the 5 most similar protocols
BIK1 phosphorylation was determined by a BIK1 mobility shift as previously described (Lu et al., 2010 (link)). Protoplasts were transfected with BIK1-HA construct and treated with 1 μM flg22 for 15 min. Total proteins were extracted using an extraction buffer [10 mM HEPES, pH 7.5, 100 mM NaCl, 1 mM EDTA, 10% glycerol, 0.5% Triton X-100, and 1x protease inhibitor cocktail (Roche)], and treated with calf intestine phosphatase (New England Biolabs) to trigger dephosphorylation. Extracted proteins were subjected to boiling in 2X Laemmli sample buffer (100 mM Tris-HCl, pH 6.8, 10% SDS, 30% glycerol, 5% β-mercaptoethanol, and 0.02% bromophenol blue), separated by SDS-PAGE, and visualized by immunoblotting with anti-HA antibody (Abcam).
+ Open protocol
+ Expand
3

Invadopodia and Cytoskeletal Protein Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
For invadopodia assays, the FISH (Tks5) antibody was obtained from Santa Cruz, and the cortactin antibody was obtained from Millipore. For immunoblotting, the human NMHC-IIA and NMHC-IIB C- terminal antibodies were produced in-house [25 (link)], and the NMHC-IIA pS1943 antibodies were produced in collaboration with Millipore and Cell Signaling Technology. The NMHC-IIA 2B3 monoclonal antibody from Abeam was used to recognize the exogenously expressed mouse GFP-NMHC-IIA. The β-actin and vinculin antibodies were purchased from Sigma. MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenylte- trazolium bromide) was obtained from Invitrogen. Calf intestine phosphatase (CIP) and lambda protein phosphatase (lambda PP) were obtained from New England Biolabs. shRNAs against the human NMHC- IIA were obtained from Open Biosystems (sh5: clone TRC 0000029465, 5’CGCATCAACTTTGATGTCAAT3’ and sh7: clone TRC0000029467, 5’CCGCGAAGTCAGCTCCCTAAA3’). The control shRNA (shC) was obtained from Sigma (MISSION® pLKO.l-puro non-target shR NA control plasmid). Recombinant human proMMP9 was from R&D Systems (cat #911-MP-010) and recombinant human MMP2 was from Calbiochem (cat #PF023).
+ Open protocol
+ Expand
4

Glucosylation and Phosphatase Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Chemicals were from Carl Roth
(Karlsruhe, Germany) and Sigma-Aldrich (Vienna, Austria). 4MU (3, Figure 1; ≥98%), 4NP (4, Figure 1; ≥99%) and 4NP-β-d-glucoside (≥98%) were from Sigma-Aldrich. 4MU-β-d-glucoside, UDP disodium salt, and UDP-glucose disodium salt
were from Carbosynth (Compton, U.K.). 15HCM (1, Figure 1; ≥99.5%)
and 15HCM β-d-glucoside (5, Figure 1; ≥99%) were provided
by BASF. Note: 15HCM is a racemic mixture of the (3R, 5R, 6S) and (3S, 5S, 6R) forms (Figure 1). 15HCM and the glycosylated
derivatives thereof are toxic and irritant. Proper care was taken
in their handling. Calf intestine phosphatase (CIP, 10 000
U/mL) was from New England Biolabs (Frankfurt am Main, Germany).
+ Open protocol
+ Expand
5

Phosphatase Treatment of HeLa Cell Lysate

Check if the same lab product or an alternative is used in the 5 most similar protocols
HeLa cells (5 × 106), treated as indicated, were lysed in 750 µL lysis buffer (containing 20 mM Tris/HCl, pH 8.0, 50 mM KCl, 2 mM MgCl2, [v/v] 0.2% NP-40) containing protease inhibitors; 40 µL lysate were incubated with CutSmart Buffer (1× final, New England Biolabs) and 15 units calf intestine phosphatase (CIP, 10 units/µL, New England Biolabs) for 45 min at 37°C. Reactions were stopped by adding 2× SDS-PAGE loading buffer and denaturation for 5 min at 95°C.
+ Open protocol
+ Expand
6

Drosophila FoxO Interaction and Phosphorylation

Check if the same lab product or an alternative is used in the 5 most similar protocols

Drosophila S2R+ cells were cultured in Corning Insectagro DS2 with 10% FBS (HyClone). Plasmids pUAST-Flag-dFoxO, pUAST-3HA-Pelle and Actin-GAL4 were used for co-transfection as indicated using Effectene Transfection Reagent (QIAGEN). 48 hours after transfection, cells were lysed in RIPA buffer (CST) with PMSF and proceeded with the standard western blot and co-immunoprecipitation protocols. Proteins were probed or immunoprecipitated with following antibodies: Flag-Tag antibody [3A6] (CMCTAG), HA-Tag (C29F4) Rabbit mAb (CST), Anti dFoxO (Cosmo Bio), Anti-rabbit IgG, HRP-linked Antibody (CST), Anti-mouse IgG, HRP-linked Antibody (CST). For Phosphatase Treatment, cell extracts were incubated with calf intestine phosphatase (CIP) (New England BioLabs) for 40 mins at 37°C.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!